Acorda Therapeutics, Inc. (ACORQ)
Aug 22, 2024 - ACORQ was delisted (reason: shares cancelled)
0.0100
0.00 (0.00%)
Inactive · Last trade price
on Aug 23, 2024
Acorda Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Net Income | -263.43 | -252.85 | -65.92 | -103.95 | -99.59 | -272.97 | Upgrade
|
| Depreciation & Amortization | 24.64 | 31.67 | 32.81 | 33.65 | 40.9 | 33.97 | Upgrade
|
| Other Amortization | 19.98 | 19.11 | 16.92 | 16.58 | 16.82 | 16.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 57.7 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 251.32 | 251.32 | - | - | 4.13 | 277.56 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.56 | -1.65 | Upgrade
|
| Stock-Based Compensation | 0.54 | 0.48 | 1.49 | 3 | 8.1 | 14.25 | Upgrade
|
| Other Operating Activities | -43.51 | -52.88 | -7.93 | -15.55 | -77.67 | -154.26 | Upgrade
|
| Change in Accounts Receivable | -0.01 | -3.43 | 2.59 | 3.19 | 1.89 | 1.35 | Upgrade
|
| Change in Inventory | -0.65 | -3.4 | 5.8 | 7.86 | -3.46 | 3.79 | Upgrade
|
| Change in Accounts Payable | -4.7 | 0.88 | -7.36 | 1.11 | -8.97 | -60.56 | Upgrade
|
| Change in Other Net Operating Assets | -11.33 | -4.88 | 0.68 | 12.78 | -1.42 | 14.02 | Upgrade
|
| Operating Cash Flow | -27.15 | -13.98 | -20.92 | -41.35 | -61.01 | -128.17 | Upgrade
|
| Capital Expenditures | -0.26 | -0.26 | -0.14 | -0.17 | -4.39 | -90.43 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 73.97 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.03 | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | 63.75 | 89.92 | Upgrade
|
| Investing Cash Flow | -0.26 | -0.26 | -0.14 | 73.78 | 59.36 | -0.51 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -69.66 | -0.6 | -55.81 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -69.66 | -0.6 | -55.81 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 0.02 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -0.09 | Upgrade
|
| Other Financing Activities | - | - | - | - | -1.07 | -4.67 | Upgrade
|
| Financing Cash Flow | - | - | - | -69.66 | -1.67 | -60.55 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | 0.19 | 0.51 | -0.45 | 1.02 | 0.06 | Upgrade
|
| Net Cash Flow | -27.42 | -14.06 | -20.55 | -37.67 | -2.3 | -189.16 | Upgrade
|
| Free Cash Flow | -27.42 | -14.25 | -21.06 | -41.51 | -65.4 | -218.59 | Upgrade
|
| Free Cash Flow Margin | -23.70% | -12.11% | -17.76% | -32.16% | -42.75% | -113.61% | Upgrade
|
| Free Cash Flow Per Share | -22.07 | -11.47 | -20.83 | -78.17 | -161.79 | -551.52 | Upgrade
|
| Cash Interest Paid | 12.42 | 12.42 | 7.16 | 0.01 | 6.67 | 6.06 | Upgrade
|
| Cash Income Tax Paid | 0.81 | 0.8 | 0.2 | 0.05 | 0.25 | 2.79 | Upgrade
|
| Levered Free Cash Flow | 6.01 | 20.14 | 13.26 | 72.58 | -101.72 | -168.6 | Upgrade
|
| Unlevered Free Cash Flow | 6.29 | 20.74 | 15.21 | 75.07 | -99.03 | -170.66 | Upgrade
|
| Change in Net Working Capital | 3.57 | -3.4 | -6.97 | -82.88 | 89.95 | 56.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.